The University of Michigan is one of eight sites around the country that will enroll patients in a clinical trial to evaluate the safety and efficacy of a technology that uses ultrasound to treat liver tumors.
Having an Erdheim-Chester Disease (ECD) referral center located in this region will help the 12 Michigan-based patients currently registered with ECDGA.
ApoE, an apolipoprotein known to play roles in cardiovascular disease and Alzheimer’s, is elevated in the blood of people with pancreatic adenocarcinoma, according to this new research.
The University of Michigan Rogel Cancer Center has named two new assistant directors, Elena Stoffel, M.D., M.P.H. and Lawrence An, M.D., to help facilitate and enhance its community outreach and engagement efforts.
Research suggests stopping the interaction between KRAS and the protein AGO2 slowed tumor growth in mouse models and lead to better treatment for non-small cell lung cancer.
Long noncoding RNAs (lncRNAs) are known to play important roles in cancer, but very little is known about their roles in the context of the immune system’s response to cancer.
A team of scientists affiliated with the led by the University of Michigan Rogel Cancer Center and School of Dentistry, identified a mechanism by which head and neck cancer cells subvert adjacent normal tissue, allowing small clusters of cancer cells to burrow beneath the healthy tissue.
MENU